Value through Innovation27 July 2016

Clinical Study Results

  • BI 113823 - Healthy
    Clinical Study Number 1272.1
    Study Indication Healthy
    Product BI 113823
    Generic Name BI 113823
    Lab Code
    Clinical Phase I
    Study Title

    Investigation of safety, tolerability and pharmacokinetics of single rising oral doses of 5 to 800 mg BI 113823 Powder in Bottle (PiB) and tablet administered to healthy male volunteers in a partially randomised and double-blinded, placebo-controlled phase I trial. Including intra-individual open comparisons of PiB and tablet (fasted and fed)

    Study Document Trial synopsis 1272.1_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.